Home › HIV › District of Columbia › Washington
HIV clinical trials in Washington, DC
22 studies for HIV are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Viral Load in Blood and Lymph Tissues in People Living With HIV
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RecruitingPhase 3
- GSK Investigational Site, Washington D.C.
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RecruitingPhase 1/2Healthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
El Camino HIV Prevention and Care Study
Recruiting
- La Clínica del Pueblo, Washington D.C.
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
RecruitingPhase 2/3
- Whitman-Walker Institute ( Site 1538), Washington D.C.
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Recruiting
- George Washington University, Washington D.C.
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RecruitingObservational study
- George Washington University, Washington D.C.
The DC Cohort Longitudinal HIV Status Neutral Study
RecruitingObservational studyHealthy volunteers welcome
- Kaiser Permanente Mid-Atlantic States, Washington D.C.
- Unity Health Care, Washington D.C.
- Georgetown University, Washington D.C.
- and 11 more
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
RecruitingHealthy volunteers welcome
- HIPS (Harm reduction drop-in center), Washington D.C.
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RecruitingPhase 1/2
- GSK Investigational Site, Washington D.C.
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
RecruitingHealthy volunteers welcome
- Whitman-Walker Health, Washington D.C.
About HIV
HIV (human immunodeficiency virus) attacks the body’s immune system. There is no cure but it can be treated with medicines. To know if you have HIV, get tested.
HIV trials in other cities
- New York City, NY19 studies
- Houston, TX17 studies
- Miami, FL17 studies
- Baltimore, MD16 studies
- San Francisco, CA15 studies
- Chicago, IL14 studies
- Atlanta, GA14 studies
- Philadelphia, PA11 studies
- Boston, MA11 studies
- San Diego, CA10 studies
- Los Angeles, CA9 studies
- Seattle, WA8 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.